Vincristine induced unilateral ptosis.
Dejan
Skorić
S
Dragana
Bogićević
B
Ivana
Petronić
P
Borivoje
Babić
B
Marko
Petrović
P
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001763:Blepharoptosis / Q000139:chemically induced* / Q000188:drug therapy; D002675:Child, Preschool; D004594:Electrophysiology; D007839:Functional Laterality; D006801:Humans; D008297:Male; D018696:Neuroprotective Agents / Q000627:therapeutic use; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D014750:Vincristine / Q000009:adverse effects*
D000970:Antineoplastic Agents; D018696:Neuroprotective Agents; D014750:Vincristine; D011736:Pyridoxine; D011729:Pyridostigmine Bromide